Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reproxalap vs Xiidra in Dry Eye Chamber
NCT05102409Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Sep 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reproxalap in dry eye disease (DED), sponsored by Aldeyra Therapeutics. Started Sep 2021; status: completed.
02
Drugs
reproxalap
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05102409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05102409.